지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 1998.6
- 수록면
- 103 - 117 (15page)
이용수
초록· 키워드
오류제보하기
Sleep disorders are a major complaint and are among the most common reasons for consulting a doctor. Patient may experience difficulties in falling asleep, frequent awakenings during the night, or early morning awakening. The result of a disturbed night's sleep is an impairment of daytime wellbeing. The loss of the restorative function of sleep in this way leads to impaired' daytime performance and affects vital function. As a direct consequence of this interdependence of sleep and daytime wellbeing, insomnia is a 24-hour problem and the treatment of insomnia may now be considered a 24-hour therapy.
Although treatment of insomnia should be an individualized treatment approach, besides behavioral treatment of insomnia, sedative hypnotics certainly occupy a place in the treatment of insomnia.
The ideal hypnotic should induce and maintain sleep, respect the physiology of sleep, improve daytime wellbeing, induce minimal or no side effects, and be devoid of dependence and abuse potential. There, however, is no such ideal hypnotic. Although effective hypnotics are available, their use still leaves the prescribing doctor with unresolved problems. Some of the hypnotics are very potent in inducing sleep but they do not maintain sleep overnight; others are effective in inducing and maintaining sleep, but leave patients with residual effects on awakening, which interfere with their daytime mental and physical functioning.
The short-acting benzodiazepines appear to have significant advantages over the long-acting agents in several areas including daytime sedation, propensity for falls in the elderly, and respiratory depression. And short-acting agents may be more effective on the first night of administration compared with long-acting agents such as flurazepam. These reasons have been significant in leading to their widespread popularity. In contrast, the long-acting agents may be preferable when daytime sedation is desired. They are often associated with a delayed and milder withdrawal sleep disturbance. When the short-acting agents are given, however, this difficulty can be minimized by tapering the dose.
This paper reviews the proper use of sleeping pills in the primary care setting in the context of current controversy involving sedative hypnotics in general and benzodiazepine hypnotics in particular. It is concluded if the physician feels a patient's insomnia warrants symptomatic relief with medication, it is appropriate toprescribe the lowest effective dose of a hypnotic for several nights. depending on the circumstances, the physician can specify either a short-acting or a long-acting hypnotic.
Hypnotic medication is indicated for the treatment of transient and short-term insomnia. It could be also used for chronic insomnia as adjunctive treatment.
Pharmacotherapy for insomnia is often not only appropriate and safe, but highly desirable if it is selected and used properly.
Although treatment of insomnia should be an individualized treatment approach, besides behavioral treatment of insomnia, sedative hypnotics certainly occupy a place in the treatment of insomnia.
The ideal hypnotic should induce and maintain sleep, respect the physiology of sleep, improve daytime wellbeing, induce minimal or no side effects, and be devoid of dependence and abuse potential. There, however, is no such ideal hypnotic. Although effective hypnotics are available, their use still leaves the prescribing doctor with unresolved problems. Some of the hypnotics are very potent in inducing sleep but they do not maintain sleep overnight; others are effective in inducing and maintaining sleep, but leave patients with residual effects on awakening, which interfere with their daytime mental and physical functioning.
The short-acting benzodiazepines appear to have significant advantages over the long-acting agents in several areas including daytime sedation, propensity for falls in the elderly, and respiratory depression. And short-acting agents may be more effective on the first night of administration compared with long-acting agents such as flurazepam. These reasons have been significant in leading to their widespread popularity. In contrast, the long-acting agents may be preferable when daytime sedation is desired. They are often associated with a delayed and milder withdrawal sleep disturbance. When the short-acting agents are given, however, this difficulty can be minimized by tapering the dose.
This paper reviews the proper use of sleeping pills in the primary care setting in the context of current controversy involving sedative hypnotics in general and benzodiazepine hypnotics in particular. It is concluded if the physician feels a patient's insomnia warrants symptomatic relief with medication, it is appropriate toprescribe the lowest effective dose of a hypnotic for several nights. depending on the circumstances, the physician can specify either a short-acting or a long-acting hypnotic.
Hypnotic medication is indicated for the treatment of transient and short-term insomnia. It could be also used for chronic insomnia as adjunctive treatment.
Pharmacotherapy for insomnia is often not only appropriate and safe, but highly desirable if it is selected and used properly.
목차
영어초록
서론
수면 요구량
불면증의 정의
불면증의 원인
불면증의 분류
수면제의 적응증
수면제 사용의 역사적 변화
수면제의 선택에서 고려되는 약리학적 요인
수면제 사용의 금기
결론
참고문헌
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Prevalence of Insomnia and Its Related Factors in Korean Women
성인간호학회지
2007 .12
-
수면클리닉을 방문한 환자들의 불면증에 대한 인식조사
수면정신생리
2019 .01
-
갑상선장애 환자에서 불면증에 연관되는 인자
생물치료정신의학
2014 .12
-
The Effect of a Sleep Education and Hypnotics Reduction Program on Hypnotics Prescription Rate for the Hospitalized Patients with Cancer at a General Hospital
Clinical Psychopharmacology and Neuroscience
2019 .01
-
Time to Take Sleeping Pills and Subjective Satisfaction among Cancer Patients
PSYCHIATRY INVESTIGATION
2020 .01
-
임상간호사의 주간 졸림, 불면증, 수면의 질에 관한 연구
한국직업건강간호학회지
2019 .01
-
수면증진 프로그램이 노인의 수면과 면역반응에 미치는 효과
성인간호학회지
2009 .04
-
불면증 환자에서 수면시간에 대한 주관적 지각과 객관적 소견의 불일치
생물치료정신의학
2012 .12
-
Verifying sleep-induced effects by short-term oral administration of high concentrated Passiflora incarnata L. extracts in experimental animals
한국실험동물학회 학술발표대회 논문집
2018 .07
-
Cognitive Behavioral Therapy for Insomnia Reduces Hypnotic Prescriptions
PSYCHIATRY INVESTIGATION
2018 .01
-
Use of Hypnotics and Risk of Cancer: A Meta-Analysis of Observational Studies
Korean Journal of Family Medicine
2018 .01
-
Synthesis and Hypnotic Activities of N-Cbz-$\alpha$-aminoglutarimidooxy Carboxylate Derivatives
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
2008 .01
-
Pachymic Acid Enhances Pentobarbital-Induced Sleeping Behaviors via GABA-ergic Systems in Mice
Biomolecules & Therapeutics(구 응용약물학회지)
2014 .01
-
시설 노인의 수면의 질과 영향요인
성인간호학회지
2009 .02
-
수면무호흡증의 다원수면기록 소견
생물치료정신의학
1996 .12
-
자율신경 안정을 통한 불면증 치료
논문집 : 대전대학교 한의학연구소. 한의학편
2009 .01
-
담정격으로 호전된 불면증 치험례
Korean Journal of Acupuncture
2014 .01
-
불면증의 바이오피드백 치료
정신신체의학
2006 .01
이 논문의 저자 정보
이 논문과 함께 이용한 논문
[손진욱 교수의 정신의학 이야기] 잠 못 이루는 고통 : 불면증
손진욱
사목정보
2011
.07
[불면증] 잠이 보약이다 : 수면의 질이 높아야 건강한 삶을 영위할수 있다
유용구
오토저널
2010
.08
불면증과 성격 5요인의 관련성에 관한 연구
이우영
연세상담코칭연구
2015
.03
불면증 환자의 스트레스, 심리적 강인성, 사회적 지지 및 삶의 질 간의 관계
김유진
,
이혜미
,
이승연
스트레스硏究
2016
.09
비타민 B군을 함유한 균형 영양을 섭취시킨 불면증, 우울증, 정신분열증 환자들에 관한 사례 연구
송숙자
,
김명석
한국정신과학회 학술대회논문집
2002
.04
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2009-513-017205693